The Rangachari lab, at the Quebec City-Laval University Hospital Research Centre (CRCHUQ-UL), is recruiting a postdoctoral fellow to make ground-breaking contributions to a National MS Society (NMSS)-funded project on progressive MS. The start date is negotiable but is anticipated to be no later than Jan 1, 2026.

The successful candidate will use flow cytometric, next-gen sequencing, imaging and functional approaches to better understand how oxphos dysregulation contributes to lymphocytemediated tissue damage within the CNS. They will leverage our recently described mouse model that recapitulates numerous features of progressive MS (Fazazi et al., Nature Comm 2024). This is a unique opportunity to unveil novel, targetable, molecules and mechanisms for progressive MS – for which therapeutic options are currently limited.